Validfor
3 known investors
Validfor provides computerized system validation (CSV) software and consulting for the life sciences and pharmaceutical industry, covering validation management, data integrity, and quality assurance. It serves regulated companies needing to demonstrate compliance of their computerized systems.
Also known as Validfor OU · Validfor OÜ
Founders & leadership
Investors · 3
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seedApr 2026 · 2 sources
DOMiNO Ventures (lead), Angel investors, Curiosity VC
Source ↗ - Undisclosed amountpre-seed roundFeb 2026
DOMiNO Ventures (lead), Curiosity VC
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Validfor develops an AI-native digital validation platform for life sciences organizations operating in GxP-regulated environments. The product centralizes validation lifecycle management on a single modular platform covering change management, deviation management, test management and periodic review management, together with paperless workflows, electronic signatures and electronic records held in a centralized repository with access controls and full audit trails. The company positions the platform against document-centric legacy validation lifecycle management tools, replacing static documentation and manual traceability with data-driven, agent-driven workflows, dynamic traceability and continuous compliance.
The platform is built around a network of AI agents targeted at validation workflows: system understanding (analyzing system requirements and detecting changes), automated generation of validation artifacts such as protocols and reports, and continuous compliance monitoring that maintains traceability and flags compliance gaps ahead of audits. Validfor applies an iterative alternative to the traditional V-model, with continuous feedback between requirements, risk analysis, design and testing. Use cases described include computer system validation (CSV), AI/ML system validation, GxP compliance workflows and digital transformation programs.
According to a February 2026 announcement, Validfor launched its agentic digital validation platform in early 2026 and targets pharmaceutical, biotech and medtech companies, citing GxP go-live timelines as short as four weeks compared with at least four months for traditional validation lifecycles.
Founding story
The company states it grew out of its founders' direct experience with pharmaceutical validation, with a team citing more than 100 years of combined experience in roles such as Project Quality Manager, Validation Lead and Senior Validation Expert on validation projects for global pharma companies.
Business model
B2B software sold to regulated life sciences enterprises, delivered as a modular digital validation platform with configurable workflows and implementation consultation; prospects engage through demo requests and direct sales contact.
Traction
The website lists customer testimonials from validation, QA and compliance practitioners and states the platform is used by life sciences companies; the company reported plans to scale its engineering team and add autonomous testing capabilities in Q2 following its pre-seed round.
Latest developments
In February 2026 Validfor announced a $1.2M pre-seed round led by DOMiNO Ventures with participation from Curiosity VC and angel investors, following the early-2026 launch of its agentic digital validation platform. Proceeds are earmarked for product development, international growth and expanding the engineering team, with an Autonomous Testing capability planned for Q2.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Positions itself as defining a category shift from document-centric validation lifecycle management tools toward AI-native validation infrastructure, arguing that legacy systems designed around documents cannot be retrofitted with intelligence.
Agent-driven rather than manual workflows, dynamic rather than static traceability, continuous rather than reactive compliance, integrated modules across the validation lifecycle, a schematic traceability view of primary and secondary linkages, rapid pre-configured GAMP 5-based deployment, and a paperless approach framed around reducing paper waste.
Technology
An agentic AI architecture in which specialized agents analyze system requirements, detect changes, generate validation protocols, reports and documentation, and monitor compliance continuously. Additional described capabilities include an on-demand AI assistant using LLM and NLP for drafting requirements and generating test steps, AI-supported system-level and requirement-level risk assessment, machine learning with federated learning for continuous improvement while preserving data privacy and mitigating algorithmic bias, real-time dashboards and reporting, and a schematic traceability view covering primary and secondary linkages. The system is pre-configured on GAMP 5 and industry best practices and addresses 21 CFR Part 11, Annex 11, Computer Software Assurance (CSA) and ALCOA+ data integrity principles. The company lists security and privacy frameworks including ISO 27001, ISO 27701, ISO 27005, ISO 27017, ISO 27018, ISO 22301, GDPR and HIPAA.
Go-to-market
Direct enterprise sales supported by demo bookings and a self-serve product preview, inbound content marketing through a validation-focused blog, and gated resources such as 21 CFR Part 11 and Annex 11 readiness checkers and handbooks.
Pharmaceutical, biotechnology and medical device organizations that must validate computerized systems, including heads of QA and validation, validation professionals, quality assurance teams, IT departments, system owners, project managers, pharma enterprises and digital transformation teams.
Geography
Offices listed in San Francisco and Chicago (United States), Tallinn (Estonia), London (United Kingdom), Istanbul (Turkey), Munich (Germany), Amsterdam area (Netherlands), and Mumbai/Pune and Chennai (India). Services are advertised across countries including the Netherlands, Italy, Belgium, Switzerland, Portugal, Korea, Canada, the United States, Germany, Poland, India, Greece, France, Austria, Turkey, Spain, Great Britain, Ireland, Slovenia, Egypt, Bangladesh, Japan, North Macedonia, Saudi Arabia, Jordan, Finland, Puerto Rico and Iceland. The February 2026 funding announcement was datelined San Francisco.
History
Validfor is led by co-founder and CEO Omer Cimen, co-founder and COO Ugur Metinol, and Chief Product & Compliance Officer Bharani Rajendran. The company published validation-focused content through 2025, launched its agentic digital validation platform in early 2026, and announced a $1.2M pre-seed round in February 2026 under the entity name Validfor OU.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 2
launches, deals, and filingsValidfor announced a $1.2M pre-seed round led by DOMiNO Ventures with participation from Curiosity VC and angel investors, to accelerate product development and expand its AI-powered compliance platform for pharma, biotech and medtech customers.
$1.2M source ↗
In early 2026 Validfor officially launched its agentic digital validation platform for pharmaceutical and life sciences companies, supporting structured, audit-ready GxP validation.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Validforvalidfor.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Validfor do?
- Validfor is an AI-native, agent-driven digital validation platform for GxP-regulated life sciences companies.
- Who founded Validfor?
- Validfor was founded by Omer Cimen, Ugur Metinol.
- Who are Validfor's investors?
- Validfor's investors include DOMiNO Ventures, Curiosity VC.